Company: LIMN
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001104659-25-055078
Chunk: 4

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 4
---
’s control, which could cause the actual results to differ materially from the expected results.
These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance
metrics, revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, other
performance metrics, projections of market opportunity, expected management and governance of the Company. These statements are based
on various assumptions, whether or not identified in this Report, and on the current expectations of the Company’s management and
are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended
to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or
probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. The risk factors
and cautionary language contained in this Report, and incorporated herein by reference, provide examples of risks, uncertainties and events
that may cause actual results to differ materially from the expectations described in such forward-looking statements, including among
other things:

| · | changes in the competitive industries and markets in which the Company operates or plans to operate; |

| · | changes in applicable laws or regulations affecting the Company’s business; |

| · | the Company’s ability to implement business plans, forecasts, and other expectations after the completion 
 of the Business Combination, and identify and realize additional opportunities;                           |

| · | risks related to the Company’s potential inability to achieve or maintain profitability and generate 
 significant revenue;                                                                                 |

| · | current and future conditions in the global economy, including as a result of economic uncertainty, and 
 its impact on the Company, its business and the markets in which it operates;                           |

| · | the Company’s potential inability to manage growth effectively; |

<div align='center'>2</div>

| · | the Company’s ability to recruit, train and retain qualified personnel; |

| · | estimates for the prospects and financial performance of the Company’s business may prove to be 
 incorrect or materially different from actual results;                                          |

| · | costs related to the Business Combination and the failure to realize anticipated benefits of the Business 
 Combination;                                                                                              |

| · | risks related to the Company’s marketing and growth strategies; |

| · | the effects of competition on the Company’s business; |

| · | expectations with respect to future operating and financial performance and growth, including when the 
 Company will generate positive